Agilent Technologies provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The company was founded in 1999 and is based in Santa Clara, California.
A Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for A, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Agilent Technologies Inc ranked in the 18th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Agilent Technologies Inc ended up being:
As a business, A is generating more cash flow than 74.3% of positive cash flow stocks in the Healthcare.
The business' balance sheet suggests that 7% of the company's capital is sourced from debt; this is greater than merely 17.52% of the free cash flow producing stocks we're observing.
A's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 41.5% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
BIO, DHR, AZN, BHC, and CNMD can be thought of as valuation peers to A, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Agilent Technologies (A) declares $0.18/share quarterly dividend, in line with previous.Forward yield 0.72%Payable Oct. 28; for shareholders of record Oct. 6; ex-div Oct. 5.See A Dividend Scorecard, Yield Chart, & Dividend Growth....